1. Hepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver. Winnick JJ, An Z, Ramnanan CJ, Smith M, Irimia JM, Neal DW, Moore MC, Roach PJ, Cherrington AD (2011) Diabetes 60(2): 398-407
    › Primary publication · 21270252 (PubMed) · PMC3028338 (PubMed Central)
  2. Diet-induced impaired glucose tolerance and gestational diabetes in the dog. Moore MC, Menon R, Coate KC, Gannon M, Smith MS, Farmer B, Williams PE (2011) J Appl Physiol (1985) 110(2): 458-67
    › Primary publication · 21088210 (PubMed) · PMC3043793 (PubMed Central)
  3. Comparison of insulins detemir and glargine: effects on glucose disposal, hepatic glucose release and the central nervous system. Moore MC, Smith MS, Turney MK, Boysen S, Williams PE (2011) Diabetes Obes Metab 13(9): 832-40
    › Primary publication · 21554521 (PubMed) · PMC3144987 (PubMed Central)
  4. Chronic consumption of a high-fat/high-fructose diet renders the liver incapable of net hepatic glucose uptake. Coate KC, Scott M, Farmer B, Moore MC, Smith M, Roop J, Neal DW, Williams P, Cherrington AD (2010) Am J Physiol Endocrinol Metab 299(6): E887-98
    › Primary publication · 20823448 (PubMed) · PMC3006253 (PubMed Central)
  5. Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs. An Z, Moore MC, Winnick JJ, Farmer B, Neal DW, Lautz M, Smith M, Rodewald T, Cherrington AD (2009) Eur J Pharmacol 607(1-3): 251-7
    › Primary publication · 19326481 (PubMed) · PMC2775505 (PubMed Central)
  6. A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin. Winnick JJ, An Z, Moore MC, Ramnanan CJ, Farmer B, Shiota M, Cherrington AD (2009) Am J Physiol Endocrinol Metab 297(2): E358-66
    › Primary publication · 19470836 (PubMed) · PMC2724107 (PubMed Central)
  7. Portal infusion of amino acids is more efficient than peripheral infusion in stimulating liver protein synthesis at the same hepatic amino acid load in dogs. Dardevet D, Kimball SR, Jefferson LS, Cherrington AD, RĂ©mond D, DiCostanzo CA, Moore MC (2008) Am J Clin Nutr 88(4): 986-96
    › Primary publication · 18842785 (PubMed) · PMC2750082 (PubMed Central)
  8. Intraportal administration of neuropeptide Y and hepatic glucose metabolism. Nishizawa M, Shiota M, Moore MC, Gustavson SM, Neal DW, Cherrington AD (2008) Am J Physiol Regul Integr Comp Physiol 294(4): R1197-204
    › Primary publication · 18234742 (PubMed)
  9. Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake. Moore MC, Dicostanzo CA, Smith MS, Farmer B, Rodewald TD, Neal DW, Williams PE, Cherrington AD (2008) Am J Physiol Endocrinol Metab 294(4): E768-77
    › Primary publication · 18212022 (PubMed)
  10. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog. An Z, DiCostanzo CA, Moore MC, Edgerton DS, Dardevet DP, Neal DW, Cherrington AD (2008) Am J Physiol Endocrinol Metab 294(2): E300-6
    › Primary publication · 18029444 (PubMed)